Digital Self-Care and Injectables: Learning from Successes and Failures

Most patients with long term conditions are performing some form of self-care as opposed to receiving professional care in hospitals. Injectable treatments have become increasingly common in the self-management of a wide range of medical conditions. However, these treatments can be complex and challenging for patients to manage, with potential risks of adverse events and suboptimal treatment outcomes. Digital self-care tools offer a promising solution to these challenges, by providing patients with the means to monitor and manage their treatments more effectively.

In today’s healthcare landscape, pharmaceutical companies have an opportunity to step up to support patients in addressing the multifaceted pain points they experience in living with their conditions. While the solution may be an obvious one, the implementation of technology in the patient journey is extremely complex: systemic challenges coupled with corporate blockers internal to pharmaceutical companies complicates the launching and scaling of digital companions. 

Join other pharmaceutical executives over breakfast at HLTH Europe and collaborate to find solutions to common systemic and operational challenges. More specifically we’ll discuss:

●  What are the most significant systemic challenges that block adoption of digital health solutions for patients on injectables?

●  What are the most significant operational challenges internal to pharmaceutical companies that prevent the launch of successful digital health solutions for patients? What are the operational challenges to start the implementation in clinical development and then transition to the Launch and Commercial phase?

●  What are the key baseline components for a feasible digital self-care program for injectable treatments?

Please note: This meeting is the second meeting in a three-part series of insights roundtables that HealthXL is hosting in collaboration with Ypsomed. Insights from this roundtable will feed into a white paper that HealthXL and Ypsomed will publish later this year. To sign up to participate in a future session, please get in touch with the HealthXL team.